Trials show semaglutide users lose about 15% of their body weight, while tirzepatide patients can lose around 21%
The authors argue that this off-label use exposes deeper tensions between medical innovation, body image ideals, and the social meanings attached to thinness, and explicitly ask whether such use should be considered an abuse of medical technology or a rational adaptation to weight-stigmatizing environments
These murine models were then presented with methylprednisolone (corticosteroid)
Thats the basis for our recommendations
This hormone not only regulates blood sugar but also curbs appetite, leading to significant weight loss benefits
This delay in treatment initiation and intensification, known as treatment inertia or clinical inertia, poses a significant risk of diseases and comorbidities associated with T2DM